146 related articles for article (PubMed ID: 9162475)
21. Mutations in the p53 and SCID genes cooperate in tumorigenesis.
Nacht M; Strasser A; Chan YR; Harris AW; Schlissel M; Bronson RT; Jacks T
Genes Dev; 1996 Aug; 10(16):2055-66. PubMed ID: 8769648
[TBL] [Abstract][Full Text] [Related]
22. p53 and human cancers.
Lane DP
Br Med Bull; 1994 Jul; 50(3):582-99. PubMed ID: 7987642
[TBL] [Abstract][Full Text] [Related]
23. To die or not to die: how does p53 decide?
Slee EA; O'Connor DJ; Lu X
Oncogene; 2004 Apr; 23(16):2809-18. PubMed ID: 15077144
[TBL] [Abstract][Full Text] [Related]
24. The role of p53 in vivo during skeletal muscle post-natal development and regeneration: studies in p53 knockout mice.
White JD; Rachel C; Vermeulen R; Davies M; Grounds MD
Int J Dev Biol; 2002; 46(4):577-82. PubMed ID: 12141446
[TBL] [Abstract][Full Text] [Related]
25. The p53 tumour suppressor gene and product.
Levine AJ
Cancer Surv; 1992; 12():59-79. PubMed ID: 1638548
[No Abstract] [Full Text] [Related]
26. p53 family in development.
Danilova N; Sakamoto KM; Lin S
Mech Dev; 2008; 125(11-12):919-31. PubMed ID: 18835440
[TBL] [Abstract][Full Text] [Related]
27. Tissue microarray analysis of maspin expression and its reverse correlation with mutant p53 in various tumors.
Zhang W; Zhang M
Int J Oncol; 2002 Jun; 20(6):1145-50. PubMed ID: 12011991
[TBL] [Abstract][Full Text] [Related]
28. Mouse models in tumor suppression.
Ghebranious N; Donehower LA
Oncogene; 1998 Dec; 17(25):3385-400. PubMed ID: 9917000
[TBL] [Abstract][Full Text] [Related]
29. Activation and activities of the p53 tumour suppressor protein.
Bálint E E; Vousden KH
Br J Cancer; 2001 Dec; 85(12):1813-23. PubMed ID: 11747320
[TBL] [Abstract][Full Text] [Related]
30. Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation.
Ashur-Fabian O; Avivi A; Trakhtenbrot L; Adamsky K; Cohen M; Kajakaro G; Joel A; Amariglio N; Nevo E; Rechavi G
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12236-41. PubMed ID: 15302922
[TBL] [Abstract][Full Text] [Related]
31. A method for estimating cancer risk in p53 mutation carriers.
Le Bihan C; Bonaiti-Pellie C
Cancer Detect Prev; 1994; 18(3):171-8. PubMed ID: 8076379
[TBL] [Abstract][Full Text] [Related]
32. To pop or not to pop: p53 as a critical modulator of tumour responsiveness to therapy in vivo?
Workman P
Hum Exp Toxicol; 1995 Feb; 14(2):222-5. PubMed ID: 7779451
[No Abstract] [Full Text] [Related]
33. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.
Jones SN; Roe AE; Donehower LA; Bradley A
Nature; 1995 Nov; 378(6553):206-8. PubMed ID: 7477327
[TBL] [Abstract][Full Text] [Related]
34. Activation of the p53 tumor suppressor protein.
Vousden KH
Biochim Biophys Acta; 2002 Mar; 1602(1):47-59. PubMed ID: 11960694
[TBL] [Abstract][Full Text] [Related]
35. 11th Ernst Klenk Lecture. The p53 tumor suppressor gene and product.
Levine AJ
Biol Chem Hoppe Seyler; 1993 Apr; 374(4):227-35. PubMed ID: 8329141
[No Abstract] [Full Text] [Related]
36. Dose and dose-rate effects of X rays and fission neutrons on lymphocyte apoptosis in p53(+/+) and p53(-/-) mice.
Fujikawa K; Hasegawa Y; Matsuzawa S; Fukunaga A; Itoh T; Kondo S
J Radiat Res; 2000 Jun; 41(2):113-27. PubMed ID: 11037579
[TBL] [Abstract][Full Text] [Related]
37. p53 protects against skin cancer induction by UV-B radiation.
Jiang W; Ananthaswamy HN; Muller HK; Kripke ML
Oncogene; 1999 Jul; 18(29):4247-53. PubMed ID: 10435637
[TBL] [Abstract][Full Text] [Related]
38. PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer.
Lee KH; Park JW; Sung HS; Choi YJ; Kim WH; Lee HS; Chung HJ; Shin HW; Cho CH; Kim TY; Li SH; Youn HD; Kim SJ; Chun YS
Oncogene; 2015 May; 34(22):2897-909. PubMed ID: 25043306
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis.
Guo Z; Yikang S; Yoshida H; Mak TW; Zacksenhaus E
Cancer Res; 2001 Dec; 61(23):8395-400. PubMed ID: 11731416
[TBL] [Abstract][Full Text] [Related]
40. Oncogenes and tumour suppressor genes in first trimester human fetal gonadal development.
Quenby SM; Gazvani MR; Brazeau C; Neilson J; Lewis-Jones DI; Vince G
Mol Hum Reprod; 1999 Aug; 5(8):737-41. PubMed ID: 10421801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
